Additionally, silencing of UBE2M suppressed the growth of breast cancer cells by inducing cell cycle arrest and apoptosis (Fig. 4), thereby increasing the sensitivity of cancer cells to fulvestrant both in vitro and in vivo (Figs. 5 and 6). Here, UBE2M is linked to cancer.